EPO and neoplasm: To expand the tumor-derived immature endothelial progeny, we used a culture media designed to expand immature endothelial cells ex vivo that exploited the characterized receptor expression (erythropoietin, IL3, c-kit, and Flk-1 [VEGF receptor-2]).